Weltelmi-AM 80mg Tablet is a combination antihypertensive medication containing Telmisartan 80mg and Amlodipine 5mg. Telmisartan, an angiotensin II receptor blocker (ARB), selectively inhibits the binding of angiotensin II to the AT1 receptor, thereby reducing vasoconstriction and aldosterone secretion, which leads to decreased blood pressure. Amlodipine, a dihydropyridine calcium channel blocker, inhibits calcium ion influx into vascular smooth muscle and cardiac muscle, resulting in vasodilation and reduced peripheral vascular resistance. The synergistic action of these two agents provides effective management of hypertension, improving blood pressure control in patients inadequately responsive to monotherapy. Weltelmi-AM is indicated for the treatment of essential hypertension and may be used to reduce the risk of cardiovascular events in high-risk patients. It is generally well tolerated, with common adverse effects including dizziness, headache, peripheral edema, and fatigue. Caution is advised in patients with hepatic or renal impairment, and it is contraindicated during pregnancy. Regular monitoring of blood pressure, renal function, and electrolytes is recommended during therapy. Weltelmi-AM offers a convenient once-daily dosing regimen, enhancing patient compliance in long-term hypertension management.